help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chanson, P.
Right arrow Articles by Schaison, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chanson, P.
Right arrow Articles by Schaison, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 5 1397-1402
Copyright © 1997 by The Endocrine Society


Endocrinological Oncology

Free Luteinizing-Hormone Beta-Subunit in Normal Subjects and Patients with Pituitary Adenomas

Philippe Chanson, Jacques Pantel, Jacques Young, Béatrice Couzinet, Jean-Michel Bidart and Gilbert Schaison

Service d’Endocrinologie et des Maladies de la Reproduction (P.C., J.Y., B.C., G.S.), Hôpital de Bicêtre, 94275 Le Kremlin-Bicêtre; and Département de Biologie Clinique (J.P., J.M.B.), Institut Gustave-Roussy, 94805 Villejuif, France

Address correspondence and requests for reprints to: Philippe Chanson, M.D., Service d’Endocrinologie et des Maladies de la Reproduction, CHU Bicêtre, 78 rue du Général Leclerc, F94275 Le Kremlin, Bicêtre Cedex, France.

Most clinically nonfunctioning pituitary adenomas (NFPA) are found to be gonadotropinomas when assessed by immunocytochemistry. However, they are rarely associated with increased basal plasma levels of FSH, LH and/or {alpha}-subunit. It has been claimed that the paradoxical free LHß response to TRH may be a useful clinical tool for determining the gonadotropic nature of NFPA. We used a very specific and sensitive immunoradiometric assay (IRMA) for free LHß measurement and another specific IRMA to check the absence of free CGß, to study normal subjects and 26 patients with NFPA. Basal plasma levels of LHß were undetectable in normal men and premenopausal women in the early follicular phase. In contrast, normal postmenopausal women had increased basal plasma LHß, parallel to dimeric LH and {alpha}-subunit levels. In healthy subjects, stimulation with GnRH elicited an increase in LHß while TRH was ineffective. In patients with NFPA, LHß hypersecretion was found basally and/or after stimulation with TRH in 3 of 16 men, 3 of 5 premenopausal women, and 1 of 5 postmenopausal women, i.e. 7 of 26 patients (26%). In 3 of these 7 cases, {alpha}-subunit and/or FSH levels were also increased. The LHß measurement was thus truly informative on the gonadotropic nature of NFPA in only 4 out of 26 cases (15%). In addition, increased LHß levels and/or a positive response of free LHß to TRH was observed in 3 patients with pure prolactinomas but in no patients with GH-secreting adenomas. Thus, using this very sensitive and specific IRMA, free LHß measurement is rarely helpful for determining the gonadotropic nature of NFPA.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Chanson, F. Daujat, J. Young, A. Bellucci, M. Kujas, D. Doyon, and G. Schaison
Normal Pituitary Hypertrophy as a Frequent Cause of Pituitary Incidentaloma: A Follow-Up Study
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3009 - 3015.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Cedrin-Durnerin, J.-M. Bidart, P. Robert, J.-P. Wolf, M. Uzan, and J.-N. Hugues
Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization
Hum. Reprod., May 1, 2000; 15(5): 1009 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. de Roux, J. Young, S. Brailly-Tabard, M. Misrahi, E. Milgrom, and G. Schaison
The Same Molecular Defects of the Gonadotropin-Releasing Hormone Receptor Determine a Variable Degree of Hypogonadism in Affected Kindred
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 567 - 572.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Pantel, P. Robert, F. Troalen, M. Kujas, D. Bellet, and J.-M. Bidart
Characterization of Human Lutropin Carboxyl- Terminus Isoforms
Endocrinology, February 1, 1998; 139(2): 527 - 533.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society